MapLight Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MPLT and other ETFs, options, and stocks.About MPLT
MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for brain disorders. It develops the ML-007-MA product for treatment of schizophrenia and ADP.
MPLT Key Statistics
Stock Snapshot
With a market cap of 684.91M, MapLight Therapeutics(MPLT) trades at $12.96. The stock has a price-to-earnings ratio of -2.54.
On 2026-09-14, MapLight Therapeutics(MPLT) stock moved within a range of $12.90 to $13.45. With shares now at $12.96, the stock is trading +0.5% above its intraday low and -3.6% below the session's peak.
Trading activity shows a volume of 105.06K, compared to an average daily volume of 560.18K.
The stock's 52-week range extends from a low of $9.10 to a high of $40.43.
The stock's 52-week range extends from a low of $9.10 to a high of $40.43.
Analyst ratings
85%
of 13 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.